Spleen and Liver Stiffness Evaluation by ARFI Imaging: A Reliable Tool for a Short-Term Monitoring of Portal Hypertension?

Table 1

General characteristics of the patients included in the study (BMI = body mass index; MELD = model for end-stage liver disease; ASH = alcoholic steatohepatitis; AICH = autoimmune-cholestatic hepatopathy; NASH = nonalcoholic steatohepatitis; HVPG = hepatic venous pressure gradient; LSM = liver stiffness measurement; SSM = spleen stiffness measurement).

Variable	Overall  =31	Non-responder  =17	Responder  =14	-value
Age (years)	62 (40-78)	62 (43-78)	62 (40-71)
Sex
Female	9 (29%)	6 (35%)	3 (21%)
Male	22 (71%)	11 (65%)	11 (79%)
BMI (kg/m^2)	25.2 (16.7–33.4)	26.4 (16.7–32.2)	24.8 (21.4–33.4)
Obesity
Underweight/normal	14 (45%)	5 (29%)	9 (64%)
Overweight/obesity	17 (55%)	12 (71%)	5 (36%)
Child-Pugh score
Child A	17 (55%)	8 (47%)	9 (64%)
Child B	14 (45%)	9 (53%)	5 (36%)
Liver disease etiology
NASH	5 (16%)	4 (24%)	1 (7.1%)
ASH	14 (45%)	7 (41%)	7 (50%)
AICH	4 (13%)	0 (0%)	4 (29%)
Viral	2 (6.5%)	2 (12%)	0 (0%)
Other	6 (19%)	4 (24%)	2 (14%)
MELD (pts.)	12 (7-19)	12 (7-19)	10 (7-18)	0.3
HVPG baseline (mmHg)	18 (10-27)	16 (12-21)	20.0 (10-27)	0.2
LSM baseline (m/s)	2.88 (1.31–3.76)	2.88 (2.09–3.76)	2.84 (1.31–3.34)	0.4
SSM overall baseline (m/s)	3.0 (2.27–3.59)	3.23 (2.38–3.59)	2.96 (2.27–3.34)	0.04